Literature DB >> 11309155

Effect of maternal antibodies on influenza virus-specific immune response elicited by inactivated virus and naked DNA.

D L Radu1, S Antohi, A Bot, A Miller, A Mirarchi, C Bona.   

Abstract

While vaccines are effective in adults, they are less successful in newborns and infants. Neonatal unresponsiveness to vaccines could be owing to immaturity of lymphocytes and/or to inhibition by maternal antibodies. Unresponsiveness of newborn to vaccines can be overcame by genetic immunization. In the present study we investigated the effect of maternal antibodies on the anti-influenza virus protective response in progeny born to dams immunized with plasmid containing the hemagglutinin gene or UV-inactivated virus. The effect of maternal antibodies was studied in plasmid immunized F1 mice born to BALB/c dams, previously immunized with virus or plasmid and crossed with C57BL/6 males, as well as in offspring born to BALB/c dams immunized with plasmid and then immunized with UV-inactivated WSN virus. We have found that the inhibition period of the anti-HA antibody response in offspring born to dams immunized with DNA is shorter than that of offspring born to dams immunized with virus. Furthermore, there is a persistent inhibitory effect on B cells from offspring born to dams immunized with virus or injected with antiviral monoclonal antibodies (MoAb), after the decline of maternal antibody titers. The analysis of the haemagglutinin-specific clonotype reactivity pattern of offspring born to dams immunized with inactivated influenza virus or with a plasmid showed that clonotypes producing antibodies specific for the immunizing virus strain were predominant in offspring born to dams immunized with DNA compared to those born to dams immunized with virus. Maternal antibodies do not affect cell-mediated immunity. These findings might be used to design efficient vaccination schedules for newborns and infants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309155     DOI: 10.1046/j.1365-3083.2001.00896.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

2.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

3.  Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.

Authors:  Jianjun Chen; Fenghua Zhang; Fang Fang; Haiyan Chang; Ze Chen
Journal:  BMC Infect Dis       Date:  2007-10-16       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.